Justas2010 (Talk | contribs) |
Justas2010 (Talk | contribs) |
||
Line 29: | Line 29: | ||
<p>At the beginning of the InterLab study we completed three distinct calibration protocols. At first, we performed the <strong>LUDOX Protocol</strong> in order to obtain a conversion factor to transform absorbance (Abs600) from the plate reader into a comparable OD600 measurement as would be obtained with a spectrophotometer. Next, we completed the Microsphere Protocol as it allows a standard curve of particle concentration which is used to convert Abs600 measurements to an estimated number of cells. Finally, by completing the Fluorescein Protocol we generated a standard fluorescence curve which is used to compare fluorescence output of different test devices. Completion of the calibrations ensured that we take cell measurements under the same conditions. It is worth mentioning that prior calibration, we prepared competent E. coli DH5-alpha cells and transformed them according to the standard transformation protocol. During all of the experiments we tested 8 plasmids: 2 controls and 6 test devices (Table 1). </p> | <p>At the beginning of the InterLab study we completed three distinct calibration protocols. At first, we performed the <strong>LUDOX Protocol</strong> in order to obtain a conversion factor to transform absorbance (Abs600) from the plate reader into a comparable OD600 measurement as would be obtained with a spectrophotometer. Next, we completed the Microsphere Protocol as it allows a standard curve of particle concentration which is used to convert Abs600 measurements to an estimated number of cells. Finally, by completing the Fluorescein Protocol we generated a standard fluorescence curve which is used to compare fluorescence output of different test devices. Completion of the calibrations ensured that we take cell measurements under the same conditions. It is worth mentioning that prior calibration, we prepared competent E. coli DH5-alpha cells and transformed them according to the standard transformation protocol. During all of the experiments we tested 8 plasmids: 2 controls and 6 test devices (Table 1). </p> | ||
<p>Table 1. Parts received and tested during iGEM’s fifth InterLab Study</p> | <p>Table 1. Parts received and tested during iGEM’s fifth InterLab Study</p> | ||
− | + | <table> | |
<thead> | <thead> | ||
<tr> | <tr> | ||
Line 41: | Line 41: | ||
<td>Negative control</td> | <td>Negative control</td> | ||
<td><a href="http://parts.igem.org/Part:BBa_R0040">BBa_R0040</td> | <td><a href="http://parts.igem.org/Part:BBa_R0040">BBa_R0040</td> | ||
− | <td>Medium strength promoter, promoter is constitutive and repressed by TetR</td> | + | <td>Medium strength promoter, promoter is constitutive and repressed by TetR |
+ | </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Positive Control</td> | <td>Positive Control</td> | ||
− | <td> | + | <td><a href="http://parts.igem.org/Part:BBa_I20270">BBa_I20270</td> |
− | <td> | + | <td>J23151 inserted in the Promoter MeasKit</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 1</td> | <td>Test Device 1</td> | ||
− | <td> | + | <td><a href="http://parts.igem.org/Part:BBa_J364000">BBa_J364000</td> |
− | <td> | + | <td>GFP expressing constitutive device</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 2</td> | <td>Test Device 2</td> | ||
− | <td> | + | <td><a href="http://parts.igem.org/Part:BBa_J364001">BBa_J364001</td> |
− | <td> | + | <td>GFP expressing constitutive device</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 3</td> | <td>Test Device 3</td> | ||
− | <td> | + | <td><a href="http://parts.igem.org/Part:BBa_J364002">BBa_J364002</td> |
− | <td> | + | <td>GFP expressing constitutive device</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 4</td> | <td>Test Device 4</td> | ||
− | <td> | + | <td><a href="http://parts.igem.org/Part:BBa_J364007">BBa_J364007</td> |
− | <td> | + | <td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 5</td> | <td>Test Device 5</td> | ||
− | <td> | + | <td><a href="http://parts.igem.org/Part:BBa_J364008">BBa_J364008</td> |
− | <td> | + | <td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 6</td> | <td>Test Device 6</td> | ||
− | <td> | + | <td><a href="http://parts.igem.org/Part:BBa_J364009">BBa_J364009</td> |
− | <td> | + | <td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> |
</tr> | </tr> | ||
</tbody> | </tbody> |
Revision as of 01:08, 17 October 2018
InterLab
Studying Fluorescence
The goal of this year’s InterLab Study was to identify and minimize the sources of systematic variability in fluorescence measurements by normalizing to absolute cell count or colony-forming units (CFUs) instead of optical density (OD).
Participating in the fifth iGEM InterLab Study was a great opportunity to start this year’s competition as well as acquire some valuable knowledge which we implemented into practice during the project.